Kristie Downing

Title: Kristie Downing: Innovator in Therapeutic Formulations

Introduction

Kristie Downing is a notable inventor based in Bend, OR (US). She has made significant contributions to the field of therapeutic formulations, particularly in the treatment of central nervous system diseases. Her innovative work has led to the development of a patent that showcases her expertise and dedication to advancing medical science.

Latest Patents

Kristie Downing holds a patent for "Therapeutic formulations and uses thereof." This invention relates to formulations of compound (I) (BNC210), an allosteric modulator of the α7-nicotinic receptor with non-sedative anxiolytic effects. Specifically, it includes solid dispersions, methods of manufacture, and therapeutic methods and uses in treating diseases of the central nervous system. She has 1 patent to her name, reflecting her commitment to innovation in this critical area of healthcare.

Career Highlights

Downing is associated with Bionomics Inc., a company dedicated to developing innovative therapies for various medical conditions. Her role at Bionomics Inc. allows her to collaborate with other talented professionals in the field, further enhancing her contributions to medical research and development.

Collaborations

Some of her notable coworkers include Dharam Paul and Julia Crossman. Their collaborative efforts contribute to the advancement of therapeutic solutions and the overall mission of Bionomics Inc.

Conclusion

Kristie Downing's work in therapeutic formulations exemplifies her innovative spirit and dedication to improving healthcare outcomes. Her contributions are paving the way for new treatments that can significantly impact patients' lives.